Central Serous Chorioretinopathy and Ocular Comorbidities
Anindya Samanta1, Matthew Driban2, Niroj Sahoo3
1Department of Ophthalmology, Baylor College of Medicine, Houston, TX 77030, USA.
Journal of Clinical Medicine
|February 13, 2025
Summary
Central serous chorioretinopathy (CSCR) often co-occurs with other eye diseases. This study found significant odds of coexisting branch retinal vein occlusion and non-exudative age-related macular degeneration in eyes with CSCR.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Ocular Comorbidities
Background:
- Central serous chorioretinopathy (CSCR) is a common condition.
- CSCR can present alongside other ocular diseases, necessitating research into these comorbidities.
- Understanding concurrent conditions is crucial for comprehensive patient care.
Purpose of the Study:
- To investigate the prevalence and patterns of ocular comorbidities in patients with CSCR.
- To identify specific diseases that frequently coexist with CSCR.
- To determine if CSCR eyes have increased odds of certain comorbid conditions compared to non-CSCR eyes.
Main Methods:
- Retrospective, multicentric, cross-sectional observational study.
- Reviewed medical charts of 9157 patients.
- Identified 579 patients (6.32%) with CSCR and at least one additional ocular comorbidity.
Main Results:
- The most common macular comorbidities were non-proliferative diabetic retinopathy (26.8%) and non-exudative age-related macular degeneration (AMD) (7.6%).
- Prevalent non-macular comorbidities included lattice degeneration (8.9%) and optic atrophy (5.1%).
- Eyes with CSCR showed statistically significant increased odds for branch retinal vein occlusion (OR 11.56) and non-exudative AMD (OR 2.06).
Conclusions:
- Certain ocular diseases demonstrate a higher likelihood of coexisting with CSCR.
- CSCR eyes exhibit significantly increased odds for specific comorbidities, such as branch retinal vein occlusion and non-exudative AMD.
- These findings highlight the importance of screening for comorbidities in CSCR patients.
More Related Videos
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
170
03:35Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
Published on: December 1, 2023
275
Related Concept Videos
01:25Glaucoma: Overview
496
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
496
01:22Photoreceptors and Visual Pathways
5.6K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.6K
01:27Open Angle Glaucoma: Treatment
386
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
386
01:28Angle Closure Glaucoma: Treatment
432
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
432